{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:37:52Z","timestamp":1773085072762,"version":"3.50.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Solid organ transplant recipients are at risk of severe coccidioidomycosis and are given prophylaxis to mitigate the risk. Patients with seropositive testing typically receive lifelong prophylaxis; currently, this prophylaxis strategy includes patients who are positive only for IgM by enzyme immunoassay (EIA-IgM-only), although this result may be falsely positive.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We conducted a retrospective study at a large-volume transplant center in an endemic coccidioidomycosis region to compare outcomes of non\u2013lung transplant recipients who were seropositive for <jats:italic toggle=\"yes\">Coccidioides<\/jats:italic> but discontinued prophylaxis (case patients) to outcomes of patients who continued prophylaxis (controls).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>No case or control patients developed active coccidioidomycosis during the follow-up period. Before transplant, 62 of 77 case patients (80.5%) had a single positive serologic test, of whom 27 of 62 were EIA-IgM-only positive (43.5%). In contrast, 57 of 77 controls (74.0%) had a single seropositive result (16\/57 [28.1%] were EIA-IgM-only). The single EIA-IgM-only result was classified as falsely positive by infectious disease consultants in 20 of 43 patients (46.5%) compared with all other <jats:italic toggle=\"yes\">Coccidioides<\/jats:italic> serologic results (13\/111 [11.7%], <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001). Lifetime antifungal prophylaxis was felt to be unnecessary for 28 of 43 patients (65.1%) who were EIA-IgM-only versus 31 of 111 patients (27.9%) with other serologic results (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>For patients repeatedly positive for EIA-IgM-only and no evidence of seroconversion, compatible clinical illness, or radiographic findings, discontinuing antifungal prophylaxis may be reasonable after the first posttransplant year.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000005304","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T16:00:10Z","timestamp":1737129610000},"page":"1251-1256","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of Coccidioides Seropositive Solid Organ Transplant Recipients After Self-discontinuation of Antifungal Prophylaxis: The EIA-IgM-only Conundrum"],"prefix":"10.1097","volume":"109","author":[{"given":"Simran","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Medicine, Mayo Clinic School of Graduate Medical Education, Mayo Clinic College of Medicine and Sciences, Scottsdale, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt V.","family":"Biondi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mayo Clinic School of Graduate Medical Education, Mayo Clinic College of Medicine and Sciences, Scottsdale, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyal J.","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Buras","sequence":"additional","affiliation":[{"name":"Division of Clinical Trials and Biostatistics, Mayo Clinic, Scottsdale, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavanya","family":"Kodali","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.H.","family":"Chascsa","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holenarasipur R.","family":"Vikram","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janis E.","family":"Blair","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"R1-20250624","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/cid\/ciw538","article-title":"Executive Summary: 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis.","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R2-20250624","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/cid\/ciac882","article-title":"The geographic distribution of dimorphic mycoses in the United States for the modern era.","volume":"76","author":"Mazi","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"Supplement_1","key":"R3-20250624","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1093\/mmy\/myy095","article-title":"Update on the Epidemiology of coccidioidomycosis in the United States.","volume":"57","author":"McCotter","year":"2019","journal-title":"Med Mycol"},{"key":"R4-20250624","doi-asserted-by":"crossref","first-page":"ofac097","DOI":"10.1093\/ofid\/ofac097","article-title":"Economic burden of fungal diseases in the United States.","volume":"9","author":"Benedict","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"R5-20250624","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3390\/jof8111157","article-title":"Fluconazole failure in the treatment of coccidioidal meningitis.","volume":"8","author":"Gupta","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"R6-20250624","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/s-2008-1063855","article-title":"Pulmonary coccidioidomycosis.","volume":"29","author":"Spinello","year":"2008","journal-title":"Semin Respir Crit Care Med"},{"key":"R7-20250624","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3390\/jof8070666","article-title":"Update on the epidemiology, diagnosis, and treatment of coccidioidomycosis.","volume":"8","author":"Williams","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"R8-20250624","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1086\/323463","article-title":"Coccidioidomycosis in solid organ transplantation.","volume":"33","author":"Blair","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R9-20250624","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/MOT.0000000000000668","article-title":"Coccidioidomycosis in solid organ transplant recipients.","volume":"24","author":"Nanayakkara","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"key":"R10-20250624","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-6143.2010.03328.x","article-title":"Coccidioidomycosis in liver transplant recipients in an endemic area.","volume":"11","author":"Vucicevic","year":"2011","journal-title":"Am J Transplant"},{"key":"R11-20250624","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1111\/ajt.15324","article-title":"De novo coccidioidomycosis among solid organ transplant recipients 1 or more years after transplant.","volume":"19","author":"Asbury","year":"2019","journal-title":"Am J Transplant"},{"key":"R12-20250624","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archinte.1982.00340160069017","article-title":"Coccidioidomycosis in renal replacement therapy.","volume":"142","author":"Cohen","year":"1982","journal-title":"Arch Intern Med"},{"key":"R13-20250624","first-page":"525","article-title":"Coccidioidomycosis and heart transplantation.","volume":"12","author":"Hall","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"R14-20250624","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1053\/jlts.2003.50125","article-title":"Incidence and prevalence of coccidioidomycosis in patients with end-stage liver disease.","volume":"9","author":"Blair","year":"2003","journal-title":"Liver Transpl"},{"key":"R15-20250624","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tid.12713","article-title":"Coccidioidomycosis among persons undergoing lung transplantation in the coccidioidal endemic region.","volume":"19","author":"Chaudhary","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"R16-20250624","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1196\/annals.1406.009","article-title":"Coccidioidomycosis in patients who have undergone transplantation.","volume":"1111","author":"Blair","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R17-20250624","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/TP.0b013e31821c1df6","article-title":"Reactivation of coccidioidomycosis despite antifungal prophylaxis in solid organ transplant recipients.","volume":"92","author":"Keckich","year":"2011","journal-title":"Transplantation"},{"key":"R18-20250624","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11046-006-0062-5","article-title":"Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts.","volume":"162","author":"Blair","year":"2006","journal-title":"Mycopathologia"},{"key":"R19-20250624","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/ajt.12144","article-title":"The utility of diagnostic testing for active coccidioidomycosis in solid organ transplant recipients.","volume":"13","author":"Mendoza","year":"2013","journal-title":"Am J Transplant"},{"key":"R20-20250624","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/jof9050513","article-title":"Diagnostic approach to coccidioidomycosis in solid organ transplant recipients.","volume":"9","author":"Zangeneh","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"R21-20250624","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3949\/ccjm.89a.21125","article-title":"Do all patients with primary pulmonary coccidioidomycosis need antifungal therapy?","volume":"89","author":"Gupta","year":"2022","journal-title":"Cleve Clin J Med"},{"key":"R22-20250624","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1128\/JCM.01843-09","article-title":"False-positive IgM serology in coccidioidomycosis.","volume":"48","author":"Kuberski","year":"2010","journal-title":"J Clin Microbiol"},{"key":"R23-20250624","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1399-3062.2006.00179.x","article-title":"Coccidioidomycosis in healthy persons evaluated for liver or kidney donation.","volume":"9","author":"Blair","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"R24-20250624","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/jac\/dky501","article-title":"Tolerability of long-term fluconazole therapy.","volume":"74","author":"Davis","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"R25-20250624","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/ijd.14238","article-title":"Cutaneous effects associated with fluconazole in patients treated for coccidioidomycosis.","volume":"58","author":"Brewer","year":"2019","journal-title":"Int J Dermatol"},{"key":"R26-20250624","article-title":"R: a language and environment for statistical computing."},{"key":"R27-20250624","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12281-021-00425-7","article-title":"Coccidioidomycosis and solid organ transplantation.","volume":"15","author":"Agarwal","year":"2021","journal-title":"Curr Fungal Infect Rep"},{"key":"R28-20250624","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1086\/344777","article-title":"Recipient screening prior to solid-organ transplantation.","volume":"35","author":"Avery","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R30-20250624","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/lt.24055","article-title":"Universal fungal prophylaxis and risk of coccidioidomycosis in liver transplant recipients living in an endemic area.","volume":"21","author":"Kahn","year":"2015","journal-title":"Liver Transpl"},{"key":"R31-20250624","first-page":"63","article-title":"Clinical study of fluconazole on deep-seated fungal infections.","volume":"42","author":"Ikemoto","year":"1989","journal-title":"Jpn J Antibiot"},{"key":"R32-20250624","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/cid\/ciab752","article-title":"Universal lifelong fungal prophylaxis and risk of coccidioidomycosis in lung transplant recipients living in an endemic area.","volume":"74","author":"Truong","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R33-20250624","first-page":"e14379","article-title":"Universal azole prophylaxis for prevention of coccidioidomycosis among lung transplant recipients transferring care to a center within a highly endemic region.","author":"Goodlet","year":"2024","journal-title":"Transpl Infect Dis"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:00:34Z","timestamp":1750791634000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005304","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]}}}